Jasper Hellweg"Given the positive initial results of the melanoma study, management has updated its estimated timeline for a potential approval to 2027, accelerating our expectations for the company to achieve a return to stable growth."Oct 12, 2026
Justus Rabach"They estimate that the personalized vaccine could be commercially approved and offered to high-risk patients by the end of 2027 or the beginning of 2028."Jun 10, 2026
Yahoo Finance"[It] raised the assumed probability of melanoma approval to 100% and projected a potential launch in the first half of 2027."Aug 20, 2026
GlobalData"Assuming a full data presentation at the upcoming European Society of Medical Oncology (ESMO) 2026 congress and a regulatory filing soon after, a realistic U.S. launch could come in mid-2027."Oct 12, 2026
Moderna"If the data are positive, we would then work to prepare for a potential launch, together with our partner Merck, of this important medicine as early as in 2027."Oct 01, 2026
Stephen Hoge“Having it fully enrolled and knowing the natural history of when we’d expect those events to be, we’re cautiously optimistic ’27 is right on path.”Mar 10, 2025
UCHealth"If all goes well, a major advance in preventing the spread of melanoma, the deadliest skin cancer, could be just months away from U.S. Food and Drug Administration approval."Sep 10, 2026